NCT00436709 2014-01-06Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerNational Cancer Institute (NCI)Phase NA Unknown75 enrolled
NCT00121134 2013-12-24Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast CancerDana-Farber Cancer InstitutePhase NA Completed164 enrolled 9 charts